Health Data Insight CIC

Using data to improve outcomes in healthcare

The Simulacrum

A synthetic dataset that contains artificial patient-like cancer data for use by researchers.

Pathway Toolkit

A suite of software tools developed for use within the NHS that enables access to patient level data across the cancer pathway.


Developing a dashboard for researching the causes of missed post-colonoscopy colorectal cancers (PCCRC) in England.

CanGene CanVar

HDI is pleased to be contributing to the CanGene CanVar programme, a five-year project to centralise data and create an interface between the NHS and research groups which will underpin future expansions in genetic testing.

“We are at the start of a healthcare revolution.
Data is changing the way diseases are treated and patients are cared for.
At HDI we find and join-up complex data from across the health landscape and turn this information into insight for patients, the public and healthcare professionals.”

Dr Jem Rashbass, Medical Director, HDI

Our Aims

HDI is a social enterprise that has been set up to act as a trusted and reliable Information Broker. We aim to do three things:

Improving access

to data and insight for all existing and potential users, service providers and commissioners of healthcare services.


Providing resources

so that patients and the public understand the value of their own and other healthcare data.

Mapping care pathways

by supporting commissioners and providers in the delivery of improved care pathways and outcomes to ensure patients receive the best care.

Latest News

HDI Intern Scheme 2020

HDI Intern Scheme 2020

We are offering up to six intern places on a group project during July and August of 2020. In previous years, our intern programme assigned a single project to each…

read more
HDI symposium, 2019

HDI symposium, 2019

In November 2019, we held our 4th annual symposium in Cambridge to share some of the work we’ve been doing this year.  Over 50 people attended the day, with friends and colleagues joining us from across Public Health England, AstraZeneca, IQVIA, and the NHS. The day...

read more